GLP-1 receptors in the mesolimbic system are implicated in the modulation of reward behavior [134], while brain imaging studies document GLP-1-induced changes in brain regions related to appetite and reward, such as the insula, amygdala, putamen, and orbitofrontal cortex [135]
It is now the most common liver disorder in the Western world, with an incidence rate of over 25% 1,2,3,4
Consistency in communication also defines the TrimRx experience
Now, if you're comparing tirzepatide vs semaglutide weight loss, note that both show strong results
Consider another antidiabetic therapy
NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials